45,X/46,XY mixed gonadal dysgenesis

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:1772Q98.7
Who is this for?
Show terms as
8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

45,X/46,XY mixed gonadal dysgenesis (MGD) is a rare disorder of sex development (DSD) caused by mosaicism in which some cells have a single X chromosome (45,X) and others have a normal male sex chromosome complement (46,XY). This chromosomal mosaicism leads to abnormal development of the gonads and variable phenotypic presentation. The condition is also referred to as 45,X/46,XY mosaicism or mixed gonadal dysgenesis. Affected individuals typically have asymmetric gonadal development, most commonly a dysgenetic (streak) gonad on one side and a testis or dysgenetic testis on the other. External genitalia can range from typically female to ambiguous to typically male, depending on the degree of testicular function during fetal development. Key clinical features include ambiguous genitalia at birth, short stature (related to the 45,X cell line, similar to Turner syndrome), and an increased risk of gonadal tumors, particularly gonadoblastoma, especially in dysgenetic gonads containing Y chromosome material. Internal genital structures are also variable and may include a uterus, fallopian tubes, or Wolffian duct derivatives depending on local gonadal hormone production. Some individuals may also exhibit features associated with Turner syndrome, such as webbed neck, lymphedema, cardiac anomalies (particularly coarctation of the aorta), and renal malformations. Management of 45,X/46,XY mixed gonadal dysgenesis requires a multidisciplinary approach involving endocrinologists, urologists, gynecologists, psychologists, and geneticists. Treatment decisions are individualized and may include hormone replacement therapy (estrogen or testosterone depending on sex of rearing), surgical management of ambiguous genitalia, and prophylactic gonadectomy of dysgenetic gonads to reduce the risk of gonadoblastoma. Growth hormone therapy may be considered for short stature. Long-term monitoring for gonadal tumors, cardiovascular health, and psychosocial well-being is essential. Early genetic counseling and psychological support are important components of care for affected individuals and their families.

Also known as:

Clinical phenotype terms— hover any for plain English:

Muscle hypertrophy of the lower extremitiesHP:0008968Unilateral cryptorchidismHP:0012741Ambiguous genitalia, maleHP:0000033Ambiguous genitalia, femaleHP:0000061Penoscrotal hypospadiasHP:0000808Abnormal internal genitaliaHP:0000812Bilateral cryptorchidismHP:0008689Urogenital sinus anomalyHP:0100779EpispadiasHP:0000039ChordeeHP:0000041Abnormal scrotum morphologyHP:0000045
Inheritance

Sporadic

Usually appears on its own, not inherited from a parent

Age of Onset

Neonatal

Begins at or shortly after birth (first 4 weeks)

Orphanet ↗NORD ↗

Treatments

No FDA-approved treatments are currently listed for 45,X/46,XY mixed gonadal dysgenesis.

View clinical trials →

No actively recruiting trials found for 45,X/46,XY mixed gonadal dysgenesis at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the 45,X/46,XY mixed gonadal dysgenesis community →

No specialists are currently listed for 45,X/46,XY mixed gonadal dysgenesis.

View NORD Rare Disease Centers ↗Undiagnosed Disease Network ↗

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to 45,X/46,XY mixed gonadal dysgenesis.

Search all travel grants →NORD Financial Assistance ↗

Community

Open 45,X/46,XY mixed gonadal dysgenesisForum →

No community posts yet. Be the first to share your experience with 45,X/46,XY mixed gonadal dysgenesis.

Start the conversation →

Latest news about 45,X/46,XY mixed gonadal dysgenesis

No recent news articles for 45,X/46,XY mixed gonadal dysgenesis.

Follow this condition to be notified when news becomes available.

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Common questions about 45,X/46,XY mixed gonadal dysgenesis

What is 45,X/46,XY mixed gonadal dysgenesis?

45,X/46,XY mixed gonadal dysgenesis (MGD) is a rare disorder of sex development (DSD) caused by mosaicism in which some cells have a single X chromosome (45,X) and others have a normal male sex chromosome complement (46,XY). This chromosomal mosaicism leads to abnormal development of the gonads and variable phenotypic presentation. The condition is also referred to as 45,X/46,XY mosaicism or mixed gonadal dysgenesis. Affected individuals typically have asymmetric gonadal development, most commonly a dysgenetic (streak) gonad on one side and a testis or dysgenetic testis on the other. External

How is 45,X/46,XY mixed gonadal dysgenesis inherited?

45,X/46,XY mixed gonadal dysgenesis follows a sporadic inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.

At what age does 45,X/46,XY mixed gonadal dysgenesis typically begin?

Typical onset of 45,X/46,XY mixed gonadal dysgenesis is neonatal. Age of onset can vary across affected individuals.